Notice & Comment

Notice & Comment

Notice & Comment

The Fed’s Governance Crisis

I’ve written about the relatively new problem of chronic Fed vacancies before (see here), but we’re setting new records. With the just-announced resignation of Vice Chair Stanley Fischer 18 months before his leadership term expired, we face another potential milestone: the first time in the Fed’s history that we have only three sitting Governors. I’ll […]

Notice & Comment

Trump Can’t Revoke DACA Without Going Through Notice and Comment

President Trump is expected to announce today that his administration will end the Deferred Action for Childhood Arrivals (DACA) program, which allows undocumented immigrants who arrived in the United States before their 16th birthday to obtain work permits and certain other federal benefits. DACA beneficiaries, commonly known as “Dreamers,” are likely to challenge Trump’s decision […]

Notice & Comment

Call for Papers: Loyola Compliance Symposium “What is the Role of a Regulation if it is Not Enforced?”

Loyola Chicago has a terrific Center for Compliance Studies, which is directed by Ryan Meade. Last year I participated in the Center’s first annual symposium “Complying with Law: An Interdisciplinary Dialogue.” I’m fascinated by the field of compliance, and the role of lawyers — and administrative law — in it. Last year’s symposium was a terrific opportunity […]

Notice & Comment

FDA’s Reliance on User Fees

Cross-posted on Objective Intent. On August 18, the President signed the Food and Drug Administration Reauthorization Act of 2017 (FDARA), which reauthorized FDA to collect user fees in connection with new drugs, biologics, and medical devices for human use.  These user fee programs are colloquially known as PDUFA (innovator drugs and biologics), GDUFA (generic drugs), BsUFA […]

Notice & Comment

Revisiting Yesterday’s Rules: The Congressional Review Act, Agency Stays, and Beyond

On Thursday, September 7, I’ll moderate a free teleconference for the ABA Admin Law Section. Register here. It should be an interesting discussion about a timely issue: the Congressional Review Act and stays of rules. Here is the info: Revisiting Yesterday’s Rules: The Congressional Review Act, Agency Stays, and Beyond Both Congress and federal agencies […]

Notice & Comment

ABA AdLaw Section’s Annual Homeland Security Law Institute, September 25-27, 2017

The American Bar Association’s 12th Annual Homeland Security Law Institute (HSLI) will be held this year at George Washington University in Washington, D.C., on September 25-27, 2017.  This three-day event is one of the largest gatherings of homeland security lawyers and policymakers in the United States.  The Institute is an annual look at the state of […]

Notice & Comment

Who is Chevron for?, by Anya Bernstein

In June, the D.C. Circuit vacated part of an FCC order regulating inmate phone rates. The majority opinion focused on the FCC’s statutory jurisdiction over intra-state phone provision. But as Aaron Nielson noted on this blog, administrative law watchers may be interested in the opinion for its odd treatment of Chevron deference. As I suggest […]

Notice & Comment

Why Trump’s Renewed Push for Healthcare Reform Could Lead to Vastly Different CBO Estimates, by Sam Wice

Future Congressional Budget Office (CBO) estimates of healthcare legislation, even identical legislation to what CBO has already reviewed, may be vastly different because of the peculiarities of the reconciliation process. Despite the recent failure of healthcare legislation, President Trump has advocated for Republicans to pass a healthcare bill to replace the Affordable Care Act. However, […]